Heptyphemide

海博非明

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameHeptyphemide
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase inhibitors
TargetsHistone deacetylase
Therapy Area/IndicationsMyelodysplastic SyndromesMultiple MyelomaLymphoma +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesZhejiang Hisun Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesZhejiang Hisun Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsMyelodysplastic SyndromesMultiple MyelomaLymphoma +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A